샘플 요청 목록

 카트 문의
시장보고서
상품코드
1542793

세계의 제약 등급 염화나트륨 시장

Pharmaceutical Grade Sodium Chloride
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 102 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

제약용 염화나트륨 세계 시장 규모는 2030년까지 9억 7,370만 달러에 달할 것으로 예상됩니다.

2023년 6억 6,480만 달러로 추정되는 제약 등급 염화나트륨 세계 시장은 2030년에는 9억 7,370만 달러에 달할 것으로 예상되며, 2023-2030년간의 분석 기간 동안 5.6%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 투석 최종 용도 부문은 CAGR 6.0%를 기록하여 분석 기간 종료 시점에 4억 1,750만 달러에 도달할 것으로 예상됩니다. 주사제 최종 용도 부문은 분석 기간 동안 6.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

미국 시장 1억 7,930만 달러로 추정, 중국은 CAGR 5.1%로 성장 전망

미국의 제약용 염화나트륨 시장은 2023년 1억 7,930만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 5.1%의 연평균 복합 성장률(CAGR)로 2030년까지 1억 5,150만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 4.8%와 4.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 4.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 제약용 염화나트륨 시장 - 주요 동향 및 촉진요인 요약

순도 보장: 제약 등급 염화나트륨의 중요한 역할

일반적으로 식용 소금으로 알려진 제약용 염화나트륨은 의료 및 의약용으로 사용되는 고도로 정제된 염화나트륨입니다. 일반 식용 소금과 달리 이 등급의 염화나트륨은 오염 물질이나 불순물이 포함되어 있지 않아 민감한 용도에 대한 안전성과 효능이 보장됩니다. 염화나트륨은 정맥 내 식염수, 경구용 보충제, 주사제 희석제 등 다양한 제약 제제에서 중요한 역할을 합니다. 의약품 등급 염화나트륨의 순도와 일관성은 의약품이 엄격한 규제 기준을 충족하고 효과적인 치료를 제공하기 위해 가장 중요합니다. 염화나트륨은 투석액, 상처 관리 제품, 심지어 비강 세척제까지 다양한 용도로 사용되어 현대 의료 분야에서 그 활용도와 필수성을 강조하고 있습니다.

기술의 발전은 어떻게 의약용 염화나트륨의 품질을 향상시키는가?

기술의 발전은 제약 등급 염화나트륨의 생산과 품질 관리를 크게 향상시켰습니다. 재결정 및 막 여과와 같은 고급 정제 기술은 불순물 제거를 강화하여 전 세계 약전의 엄격한 기준을 충족하는 고순도 염화나트륨을 보장합니다. 고속 액체 크로마토그래피(HPLC), 원자흡광분석(AAS) 등 첨단 분석법을 도입하여 불순물 수준을 정확하게 모니터링하여 일관성과 안전성을 보장합니다. 또한, 제조 공정의 자동화를 통해 인적 오류를 최소화하고 생산 효율을 향상시키고 있습니다. 이러한 기술 발전은 염화나트륨의 고품질을 보장할 뿐만 아니라, 헬스케어 분야 수요 증가에 대응할 수 있는 대량 생산이 가능해졌습니다.

약용 염화나트륨을 관리하는 규제와 안전 기준은?

의약품 등급의 염화나트륨은 의료용 적합성을 보장하기 위해 엄격한 규제 및 안전 기준을 준수합니다. 미국 식품의약국(FDA)과 유럽의약품청(EMA)과 같은 규제 기관은 이 중요한 성분의 제조, 시험 및 라벨링에 대해 엄격한 가이드라인을 적용하고 있습니다. 미국 약전(USP) 및 유럽 약전(Ph.Eur.)과 같은 약전 표준을 준수해야 합니다. 이러한 표준은 불순물 허용 수준, 미생물 한계, 요구되는 물리적 및 화학적 특성을 규정합니다. 제조업체는 또한 품질 관리 시스템, 위생 기준, 문서화 절차를 포함하는 우수의약품제조관리기준(GMP)을 준수해야 합니다. 이러한 엄격한 규제를 준수함으로써 제약 등급의 염화나트륨이 의료용으로 안전하게 사용되고 최고 품질 기준을 충족할 수 있도록 보장합니다.

제약용 염화나트륨 시장의 성장을 가속하는 요인은 무엇인가?

제약용 염화나트륨 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 당뇨병 및 신장 질환과 같은 만성 질환 증가로 인해 고순도 염화나트륨이 필수적인 정맥 식염수 및 투석 치료에 대한 수요가 증가하고 있습니다. 정제 및 제조 공정의 기술 발전으로 제품 품질이 향상되고 생산 능력이 확대되어 증가하는 의료 수요에 대응하고 있습니다. 또한, 전 세계 인구 고령화로 인해 제약용 염화나트륨을 이용한 다양한 치료법에 대한 수요가 증가하고 있습니다. 의약품 제형화 및 생산에 고품질 원료를 필요로 하는 바이오 의약품 분야의 확장은 시장 성장을 더욱 촉진하고 있습니다. 또한, 엄격한 규제 기준으로 인해 제조업체는 생산 공정과 품질 관리를 지속적으로 개선하여 안전하고 효과적인 의약품 등급의 염화나트륨 공급을 보장하고 있습니다. 마지막으로, 개인 맞춤형 의료와 첨단 약물 전달 시스템에 대한 관심이 높아지면서 제약용 염화나트륨의 특수 용도에 대한 새로운 기회가 생겨나면서 시장 확대에 박차를 가하고 있습니다.

조사 대상 기업 예시(주목할 만한 12개 기업)

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co.
  • K S France S.A.S.
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co.
  • US Salt, LLC.

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 기타 유럽
    • 아시아태평양
    • 기타 지역

    제4장 경쟁

    LSH 24.09.04

    Global Pharmaceutical Grade Sodium Chloride Market to Reach US$973.7 Million by 2030

    The global market for Pharmaceutical Grade Sodium Chloride estimated at US$664.8 Million in the year 2023, is expected to reach US$973.7 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Dialysis End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$417.5 Million by the end of the analysis period. Growth in the Injections End-Use segment is estimated at 6.3% CAGR over the analysis period.

    The U.S. Market is Estimated at US$179.3 Million While China is Forecast to Grow at 5.1% CAGR

    The Pharmaceutical Grade Sodium Chloride market in the U.S. is estimated at US$179.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$151.5 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

    Global Pharmaceutical Grade Sodium Chloride Market - Key Trends and Drivers Summarized

    Ensuring Purity: The Essential Role of Pharmaceutical Grade Sodium Chloride

    Pharmaceutical grade sodium chloride, commonly known as salt, is a highly purified form of sodium chloride used in medical and pharmaceutical applications. Unlike regular table salt, this grade of sodium chloride is free from contaminants and impurities, ensuring its safety and efficacy in sensitive applications. It plays a critical role in various pharmaceutical formulations, including intravenous (IV) saline solutions, oral rehydration salts, and as a diluent for injectable drugs. The purity and consistency of pharmaceutical grade sodium chloride are paramount as they ensure that medications meet stringent regulatory standards and provide effective treatment. Its use extends to dialysis solutions, wound care products, and even as a nasal rinse, highlighting its versatility and indispensability in modern healthcare.

    How Are Technological Advancements Enhancing the Quality of Pharmaceutical Sodium Chloride?

    Technological advancements have significantly improved the production and quality control of pharmaceutical grade sodium chloride. Advanced purification techniques, such as recrystallization and membrane filtration, have enhanced the removal of impurities, ensuring high-purity sodium chloride that meets the stringent standards of pharmacopeias worldwide. The implementation of sophisticated analytical methods, including high-performance liquid chromatography (HPLC) and atomic absorption spectroscopy (AAS), allows for precise monitoring of impurity levels, ensuring consistency and safety. Furthermore, automation in manufacturing processes has minimized human error and increased production efficiency. These technological strides not only ensure the high quality of pharmaceutical sodium chloride but also enable large-scale production to meet the growing demand in the healthcare sector.

    What Are the Regulatory and Safety Standards Governing Pharmaceutical Sodium Chloride?

    Pharmaceutical grade sodium chloride is subject to rigorous regulatory and safety standards to ensure its suitability for medical use. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines on the production, testing, and labeling of this critical ingredient. Compliance with pharmacopeial standards, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), is mandatory. These standards specify the acceptable levels of impurities, microbial limits, and the required physical and chemical properties. Manufacturers must also adhere to Good Manufacturing Practices (GMP), which encompass quality management systems, hygiene standards, and documentation procedures. The adherence to these stringent regulations ensures that pharmaceutical grade sodium chloride is safe for use in medical applications and meets the highest quality standards.

    What Factors Are Driving Growth in the Pharmaceutical Grade Sodium Chloride Market?

    The growth in the pharmaceutical grade sodium chloride market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as diabetes and kidney disorders is boosting the demand for IV saline solutions and dialysis treatments, where high-purity sodium chloride is essential. Technological advancements in purification and manufacturing processes are enhancing product quality and expanding production capacity, meeting the rising healthcare needs. Additionally, the aging global population is contributing to higher demand for various medical treatments that utilize pharmaceutical grade sodium chloride. The expansion of the biopharmaceutical sector, which requires high-quality raw materials for drug formulation and production, is further propelling market growth. Furthermore, stringent regulatory standards are driving manufacturers to continuously improve their production processes and quality controls, ensuring the supply of safe and effective pharmaceutical grade sodium chloride. Lastly, the increasing focus on personalized medicine and advanced drug delivery systems is creating new opportunities for specialized applications of pharmaceutical sodium chloride, fueling market expansion.

    Select Competitors (Total 12 Featured) -

    • Akzo Nobel NV
    • Dominion Salt Ltd.
    • Hebei Huachen Pharmaceutical Co., Ltd.
    • K+S France S.A.S.
    • Morton Salt, Inc.
    • Salinen Austria Aktiengesellschaft
    • Sudwestdeutsche Salzwerke AG
    • Swiss Saltworks
    • Tianjin Changlu Haijing Group Co., Ltd.
    • US Salt, LLC.

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • World Market Trajectories
      • Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2024 (E)
      • Global Economic Update
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Increasing Demand for Injectable Drugs Drives Market Growth
      • Rising Use of Sodium Chloride in Dialysis Solutions Expands Market Opportunity
      • Growth in IV Fluid Market Propels Demand for Pharmaceutical Grade Sodium Chloride
      • Advances in Purification Technologies Enhance Product Quality
      • Increasing Investment in Healthcare Infrastructure
      • Development of Biopharmaceuticals and Biosimilars
      • Expansion of Global Pharmaceutical Manufacturing
      • Rising Focus on Drug Formulation and Stability
      • Growth in Clinical Research and Trials
      • Increasing Applications in Oral Rehydration Solutions
      • Advances in Drug Delivery Systems Impacting Sodium Chloride Usage
      • Growth in Emerging Markets Expands Addressable Market Opportunity
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 2: World Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 3: World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
      • TABLE 4: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 5: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 6: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 7: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 8: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 9: World 16-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 10: World Recent Past, Current & Future Analysis for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 11: World Historic Review for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 12: World 16-Year Perspective for Oral Rehydration Salts (ORS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
      • TABLE 16: World Pharmaceutical Grade Sodium Chloride Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 17: USA Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 18: USA Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 19: USA 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • CANADA
      • TABLE 20: Canada Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 21: Canada Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 22: Canada 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • JAPAN
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 23: Japan Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 24: Japan Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 25: Japan 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • CHINA
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 26: China Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 27: China Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 28: China 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • EUROPE
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 29: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 30: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 31: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
      • TABLE 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 33: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 34: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • FRANCE
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 35: France Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 36: France Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 37: France 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • GERMANY
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 38: Germany Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 39: Germany Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 40: Germany 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • ITALY
      • TABLE 41: Italy Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 42: Italy Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 43: Italy 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • UNITED KINGDOM
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 44: UK Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 45: UK Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 46: UK 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • REST OF EUROPE
      • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 48: Rest of Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 49: Rest of Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • ASIA-PACIFIC
      • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 51: Asia-Pacific Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 52: Asia-Pacific 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
    • REST OF WORLD
      • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 54: Rest of World Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 55: Rest of World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030

    IV. COMPETITION

    • 샘플 요청 목록
    0 건의 상품을 선택 중
    목록 보기
    전체삭제